Department of Biomedical and Neuromotor Sciences-DIBINEM, University of Bologna - IRCCS Istituto delle Scienze Neurologiche di Bologna, Padiglione G, Ospedale Bellaria, via Altura 3, Bologna, 40139, Italy.
J Headache Pain. 2013 Mar 4;14(1):22. doi: 10.1186/1129-2377-14-22.
Previous studies suggest that patients with Chronic Daily Headache (CDH) have higher levels of anxiety and depressive disorders than patients with episodic migraine or tension-type headache. However, no study has considered the presence of psychiatric comorbidity in the analysis of personality traits. The aim of this study is to investigate the prevalence of psychiatric comorbidity and specific personality traits in CDH patients, exploring if specific personality traits are associated to headache itself or to the psychiatric comorbidity associated with headache.
An observational, cross-sectional study. Ninety-four CDH patients with and without medication overuse were included in the study and assessed by clinical psychiatric interview and Mini International Neuropsychiatric Interview (M.I.N.I.) as diagnostic tools. Minnesota Multiphasic Personality Inventory-2 (MMPI-2), Hamilton Depression Rating Scale (HAM-D) were afterwards administered. Patients with and without psychiatric comorbidity were compared. Further analyses were made by splitting the whole group according to the headache diagnosis and the presence or not of medication overuse.
Psychiatric comorbidity was detected in 44 patients (46.8%) (group A) and was absent in the remaining 50 patients (53.2%) (group B). Mood and anxiety disorders were the most frequently diagnosed (43.6%).In the overall group, mean scores of MMPI-2 showed a high level in the so-called neurotic triad; in particular the mean score in the Hypochondriasis subscale was in the pathologic area (73.55 ± 13.59), while Depression and Hysteria scores were moderate but not severe (62.53 and 61.61, respectively). In content scales, score in Health Concern was also high (66.73).Group A presented higher scores compared to Group B in the following MMPI-2 subscales: Hypochondriasis (p= .036), Depression (p= .032), Hysteria (p< .0001), Hypomania (p= .030). Group B had a high score only in the Hypochondriasis subscale. No significant differences were found between chronic migraine (CM)-probable CM (pCM) plus probable medication overuse headache (pMOH) and chronic tension-type headache (CTTH)-probable CTTH (pCTTH) plus pMOH patients or between patients with and without drug overuse.
The so-called "Neurotic Profile" reached clinical level only in CDH patients with psychiatric comorbidity while a high concern about their general health status was a common feature in all CDH patients.
先前的研究表明,慢性每日头痛(CDH)患者比发作性偏头痛或紧张型头痛患者有更高水平的焦虑和抑郁障碍。然而,尚无研究在分析人格特质时考虑到精神共病的存在。本研究旨在调查 CDH 患者中精神共病和特定人格特质的患病率,探讨特定人格特质是否与头痛本身或与头痛相关的精神共病相关。
这是一项观察性、横断面研究。94 名患有和不患有药物过度使用的 CDH 患者纳入研究,并通过临床精神病学访谈和 Mini 国际神经精神访谈(MINI)进行评估,作为诊断工具。随后进行明尼苏达多相人格问卷-2(MMPI-2)和汉密尔顿抑郁评定量表(HAM-D)的评估。比较有和无精神共病的患者。进一步的分析是根据头痛诊断和是否存在药物过度使用将整个组进行分组。
44 名患者(46.8%)(A 组)存在精神共病,其余 50 名患者(53.2%)(B 组)无精神共病。情绪和焦虑障碍是最常被诊断出的疾病(43.6%)。在整个组中,MMPI-2 的平均分数显示出神经质三联征的高水平;特别是疑病症亚量表的平均分数处于病理区域(73.55 ± 13.59),而抑郁和癔症分数处于中度但非严重程度(分别为 62.53 和 61.61)。在内容量表中,健康关注量表的分数也很高(66.73)。与 B 组相比,A 组在以下 MMPI-2 子量表中得分更高:疑病症(p=0.036)、抑郁(p=0.032)、癔症(p<0.0001)、轻躁狂(p=0.030)。B 组仅在疑病症亚量表中得分较高。慢性偏头痛(CM)-可能的 CM(pCM)加可能的药物过度使用头痛(pMOH)与慢性紧张型头痛(CTTH)-可能的 CTTH(pCTTH)加 pMOH 患者之间或有和无药物过度使用的患者之间均未发现显著差异。
所谓的“神经质谱”仅在有精神共病的 CDH 患者中达到临床水平,而对自身整体健康状况的高度关注是所有 CDH 患者的共同特征。